CD8A and neoplasm: In vivo, enhancing PEP production through overexpression of PCK1, an enzyme that produced PEP from oxaloacetate, is sufficient to enhance CD4 and CD8 T cell function in murine tumor models, suggesting that glycolytic regulation of signaling is a mechanism by which glucose-replete tumors evade immune responses.79